NCT04283097
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04283097
Title Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kangpu Biopharmaceuticals, Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
BRCR Global - USA Plantation Florida 33322 United States Details
Norton Cancer Institute Louisville Kentucky 40202 United States Details
Henry Ford Health System - Hemophilia and Thrombosis Treatment Center Detroit Michigan 48202-2689 United States Details
Mohamad Medical Cherry Morristown New Jersey 07960 United States Details
Duke University Health System - Duke Endoscopy - Duke Clinic 2H Durham North Carolina 27710-4000 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
UPMC CancerCenter Pittsburgh Pennsylvania 15232 United States Details
Laguna Clinical Research Associates Laredo Texas 78041 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226-0509 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field